08.09.2017
- Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal...
26.07.2017
- US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from...
13.07.2017
- French drugmaker Sanofi is gaining access to a new type of flu vaccine after agreeing to buy Protein Sciences, a privately held vaccines biotechnology company based in Meriden...
29.03.2017
- AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the...
02.02.2017
- Pharmaserv Logistics, which specializes in pharmaceutical logistics, temperature-controlled exports and pre-wholesale solutions, has concluded a contract with vaccine manufacturer...
05.01.2017
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have completed their business swap, which sees Sanofi take Boehringer’s consumer healthcare (CHC)...
04.01.2017
- Sanofi Pasteur, the global vaccines business unit of French drugmaker Sanofi, and Merck, Sharp and Dohme, international arm of US drugmaker Merck. have ended their vaccine joint...
03.01.2017
- An experimental Ebola vaccine initially developed by the Public Health Agency of Canada and the US Army and eventually licensed to Merck, Sharp and Dohme, the international arm of...
